Stockreport

How The Arcutis Biotherapeutics (ARQT) Story Is Evolving As Analysts Cluster Around US$35 Targets [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF Arcutis Biotherapeutics is back in focus as price targets cluster around $35, with at least one firm trimming its view from $37 to $35 while others move targets from th [Read more]